Announced financings: March 7, 2024

March 8, 2024 01:14 PM PST

Here's your roundup of yesterday's announced financings, courtesy of, the only platform that posts every Canadian financing, every day.

1. Mind Medicine Inc. (NEO: MMED)

  • Gross Proceeds: $100 million; $75 million
  • Sector: Biopharmaceuticals
  • Units issued: 16.67 million; 12.5 million
  • Type: Common shares
  • Price: $6.00
  • Warrants: None
  • Agents: RBC Capital Markets; Non-brokered
  • Use of Proceeds: Working capital

Company breakdown:

  • Clinical-stage biopharmaceutical company developing products to treat brain health disorders
  • Shares recently took off in anticipation of its MM120 treatment for generalized anxiety disorder receiving breakthrough therapy designation from the US FDA
  • MM120 uses lysergide, a synthetic psychedelic

You May Like